The Use of Patient-Derived Xenograft (PDX) Models to Predict Patient Response in Non-Small Cell Lung Cancer (NSCLC)

Jakob Isler(Champions Oncology (United States)), Amanda Katz(Champions Oncology (United States)), A. Sorogin(Champions Oncology (United States)), Michael Scoppetuolo(Saint Barnabas Medical Center), Hovav Nechushtan(Hadassah Medical Center), Harvey I. Pass(NYU Langone Health), Angela M. Davies(Champions Oncology (United States)), K. Paz(Champions Oncology (United States))
International Journal of Radiation Oncology*Biology*Physics
October 30, 2014
10.1016/j.ijrobp.2014.08.226
Cited by 2Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis